HC ANDERSEN CAPITAL

ExpreS2ion Biotechnologies – Presentation of half-year 2025 report

Name: ExpreS2ion Biotechnologies - Presentation of half-year 2025 report
Start: 2025-08-21T10:30:00+0200
End: 2025-08-21T11:00:00+0200

AUTHOR

Mie

DATE

3. July 2025

ExpreS2ion Biotechnologies – Presentation of half-year 2025 report

ExpreS2ion Biotechnologies - Presentation of half-year 2025 report 21 AugustAug 2025 10:30 - 11:00Online Event

Tilmeld

Information

ExpreS2ion Biotechnologies - Presentation of half-year 2025 report 21 AugustAug 2025 10:30 - 11:00

ExpreS2ion Biotechnologies - Presentation of half-year 2025 report Online Event

Tilmeld

WindowMaster – H1 2025 interim report

GreenMobility – Presentation of H1 Interim Report 2025

Explore our services

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Adviser on Nasdaq First North Copenhagen.

About us

What we do in short

Advisory

IR Services

Our Community

ExpreS2ion Biotechnologies – Presentation of half-year 2025 report

ExpreS2ion Biotechnologies – Presentation of half-year 2025 report

Information

Explore our services

INFORMATION

About

What we do

2024 - HC Andersen Capital